{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:27Z","timestamp":1791414147441,"version":"4.3.3"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8,1]]},"DOI":"10.1093\/cid\/cis453","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T16:19:01Z","timestamp":1341245941000},"page":"S162-S169","source":"Crossref","is-referenced-by-count":115,"title":["Fidaxomicin Inhibits Spore Production in Clostridium difficile"],"prefix":"10.1093","volume":"55","author":[{"given":"Farah","family":"Babakhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Bouillaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ly","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham L.","family":"Sonenshein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,8,1]]},"reference":[{"key":"key\n\t\t\t\t20171013232845_CIS453C1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","author":"Rupnik","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C2","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile\u2013associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171013232845_CIS453C3","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhin.2009.08.016","article-title":"Historical and changing epidemiology of healthcare-associated infections","volume":"73","author":"Pearson","year":"2009","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20171013232845_CIS453C4","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.31.18942-en","article-title":"Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008","volume":"13","author":"Kuijper","year":"2008","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20171013232845_CIS453C5","article-title":"Outbreak notice","author":"Niagara Health System and Niagara Region Public Health"},{"key":"key\n\t\t\t\t20171013232845_CIS453C6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nature09397","article-title":"The role of toxin A and toxin B in Clostridium difficile infection","volume":"467","author":"Kuehne","year":"2010","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171013232845_CIS453C7","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1128\/JB.00597-09","article-title":"Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores","volume":"191","author":"Lawley","year":"2009","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/521854","article-title":"Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents","volume":"45","author":"Riggs","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013232845_CIS453C9","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/IAI.01336-10","article-title":"Mouse relapse model of Clostridium difficile infection","volume":"79","author":"Sun","year":"2011","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171013232845_CIS453C10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2334-10-268","article-title":"Improved eradication of Clostridium difficile spores from toilets of hospitalized patients using an accelerated hydrogen peroxide as the cleaning agent","volume":"10","author":"Alfa","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171013232845_CIS453C11","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1128\/JCM.38.6.2386-2388.2000","article-title":"Epidemiology of recurrences or reinfections of Clostridium difficile\u2013associated diarrhea","volume":"38","author":"Barbut","year":"2000","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1099\/jmm.0.45753-0","article-title":"Alternative treatments for Clostridium difficile disease: what really works?","volume":"54","author":"McFarland","year":"2005","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C13","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/j.ijid.2011.03.017","article-title":"Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection","volume":"15","author":"Musgrave","year":"2011","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20171013232845_CIS453C14","article-title":"Efficacy and safety of fidaxomicin (FDX) vs. vancomycin (VAN) in Clostridium difficile infection in 2 randomized control trials (RCT) with 1105 patients","author":"Crook"},{"key":"key\n\t\t\t\t20171013232845_CIS453C15","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1128\/AAC.48.12.4898-4902.2004","article-title":"In vitro activity of OPT-80 and comparator drugs against intestinal bacteria","volume":"48","author":"Finegold","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013232845_CIS453C16","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1128\/AAC.48.11.4430-4434.2004","article-title":"Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species","volume":"48","author":"Credito","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013232845_CIS453C17","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1099\/mic.0.042010-0","article-title":"A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile\u2013infected patients than does vancomycin","volume":"156","author":"Tannock","year":"2010","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20171013232845_CIS453C18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14656566.2010.485614","article-title":"Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection","volume":"11","author":"Miller","year":"2010","journal-title":"Expert Opin Pharmacol Ther"},{"key":"key\n\t\t\t\t20171013232845_CIS453C19","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/cid\/cis358","article-title":"Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis","volume":"55","author":"Artsimovitch","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171013232845_CIS453C20","first-page":"285","article-title":"Mechanism of selective toxicity of metronidazole and other nitroimidazole drugs","volume":"56","author":"Edwards","year":"1980","journal-title":"Br J Vener Dis"},{"key":"key\n\t\t\t\t20171013232845_CIS453C21","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1128\/IAI.56.9.2299-2306.1988","article-title":"Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain","volume":"56","author":"Popoff","year":"1988","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20171013232845_CIS453C22","volume-title":"Methods for antimicrobial susceptibility tests of anaerobic bacteria: approved standard M11\u2013A7","author":"Clinical and Laboratory Standards Institute","year":"2007","edition":"7th ed"},{"key":"key\n\t\t\t\t20171013232845_CIS453C23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1099\/jmm.0.029470-0","article-title":"Killing kinetics of fidaxomicin and its major metabolite, OP-1118, against Clostridium difficile","volume":"60","author":"Babakhani","year":"2011","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C24","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/mic.0.045997-0","article-title":"The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile","volume":"157","author":"McBride","year":"2011","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20171013232845_CIS453C25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2958.2007.05906.x","article-title":"Repression of Clostridium difficile toxin gene expression by CodY","volume":"66","author":"Dineen","year":"2007","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C26","author":"IDT\u00ae Integrated DNA technologies"},{"key":"key\n\t\t\t\t20171013232845_CIS453C27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))","volume":"25","author":"Livak","year":"2001","journal-title":"Method"},{"key":"key\n\t\t\t\t20171013232845_CIS453C28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1128\/AAC.01443-07","article-title":"OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection","volume":"53","author":"Louie","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171013232845_CIS453C29","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1128\/JCM.01964-07","article-title":"Increased sporulation rate of epidemic Clostridium difficile type 027\/NAP1","volume":"46","author":"Akerlund","year":"2008","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.anaerobe.2010.10.001","article-title":"The diverse sporulation characteristics of Clostridium difficile clinical isolates are not associated with type","volume":"16","author":"Burns","year":"2010","journal-title":"Anaerobe"},{"key":"key\n\t\t\t\t20171013232845_CIS453C31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1365-2958.2003.03471.x","article-title":"Efficient sporulation in Clostridium difficile requires disruption of the sigmaK gene","volume":"48","author":"Haraldsen","year":"2003","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20171013232845_CIS453C32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mimet.2011.07.017","article-title":"Sporulation studies in Clostridium difficile","volume":"87","author":"Burns","year":"2011","journal-title":"J Microbiol Methods"},{"key":"key\n\t\t\t\t20171013232845_CIS453C33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1099\/00221287-92-1-81","article-title":"The effect of sublethal doses of rifampin on the sporulation of Clostridium botulinum","volume":"92","author":"Hawirko","year":"1976","journal-title":"J Gen Microbiol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/55\/suppl_2\/S162\/20911129\/cis453.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T21:17:51Z","timestamp":1642627071000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/55\/suppl_2\/S162\/436456\/Fidaxomicin-Inhibits-Spore-Production-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,1]]},"references-count":33,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2012,8,1]]},"published-print":{"date-parts":[[2012,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis453","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2012,8,1]]},"published":{"date-parts":[[2012,8,1]]}}}